Morbidity and Mortality Weekly Report (MMWR)
| Link | https://www.cdc.gov/mmwr/index.html |
| Feed | http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5 |
| Updated | 2025-09-11 01:31 |
on (#5XYCJ)
This report describes an E. coli outbreak at an Oregon child care center.
on (#5XYCH)
This report describes a confirmed case of Monkeypox virus in the U.S.
on (#5XYCG)
This report describes 10 people who were infected with the COVID-19 Omicron variant within 90 days of Delta variant infection.
on (#5XRHK)
This report describes the risk for cardiac complications as higher after COVID-19 infection that after COVID-19 vaccination for males and females in all age groups.
on (#5XQ8M)
Findings from the first Adolescent Behaviors and Experiences Survey
on (#5XQ8K)
Findings from the first Adolescent Behaviors and Experiences Survey
on (#5XQ8J)
Findings from the first Adolescent Behaviors and Experiences Survey
on (#5XQ8H)
This report describes Xylazine-related deaths in Cook County, Illinois
on (#5XQ8G)
This report describes the percentage of office-based physician who had telehealth consults with patients in 2018 and 2020.
on (#5XQ8F)
This report describes epidemiology capacity in state health departments during the COVID-19 response.
on (#5XMN2)
This report describes vaccine effectiveness of COVID-19 booster doses after one dose of the Johnson & Johnson COVID-19 vaccine against emergency department, urgent care visits, and hospitalizations.
on (#5XGSG)
This report describes an increase in use of at-home rapid COVID-19 antigen tests between the Delta and Omicron predominant periods during August 2021 to March 2022.
on (#5XFFN)
This report describes the percentage of adults who have difficulty hearing.
on (#5XFFM)
This report describes use of intervention services among children with developmental delays, disorders, and disabilities.
on (#5XFFK)
This report describes programmatic gains of HIV treatment during the pandemic.
on (#5XFFJ)
This report describes tuberculosis incidence in the U.S. during 2021.
on (#5X8T9)
This report describes adult COVID-19 hospitalization rates by race/ethnicity during SARS-CoV-2 Delta and Omicron predominance.
on (#5X8T8)
This report describes effectiveness of mRNA COVID-19 vaccination in preventing COVID-19 associated invasive mechanical ventilation and death after receiving 2 or 3 vaccine doses.
on (#5X7GZ)
This report describes tobacco use by U.S. adults from 2019 to 2020.
on (#5X7GY)
This report describes the rate of unintentional traumatic brain injury deaths in persons 19 and younger.
on (#5X7GX)
This report describes the Advisory Committee on Immunization Practices’ recommendation for use of the Moderna COVID-19 vaccine in adults.
on (#5X7GW)
This report describes the number of end-stage kidney disease cases in the United States.
on (#5X7GV)
This report describes progress toward elimination of maternal and neonatal tetanus.
on (#5X4SN)
This report describes COVID-19 hospitalization rates among infants and children aged 0-4 years, including during Omicron variant predominance.
on (#5X0S7)
This report describes vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine as effective in protecting against Omicron infection among children and adolescents.
on (#5WZEV)
This report describes the percentage of adults who sleep less than seven hours on average.
on (#5WZET)
This report describes a case of congenital varicella syndrome in Illinois.
on (#5WZES)
This report describes COVID-19 vaccine provider access and vaccination coverage among U.S. children aged 5–11 years.
on (#5WZER)
This report describes the effect of COVID-19 on serological assays associated with dengue or Zika Virus.
on (#5WZEQ)
This report describes the treatment of Chagas disease using nifurtimox.
Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
on (#5WZEP)
This report describes the effectiveness of the influenza vaccine during the 2021-2022 flu season.
on (#5WWQE)
This report compares COVID-19 incidence in Arkansas K–12 school districts between those with mask requirements versus those without mask requirements.
on (#5WQJE)
This report describes the percentage of adults with kidney disease in the United States
on (#5WQJD)
This report describes initial reports of hantavirus infection in District of Columbia during 2018.
on (#5WQJC)
This report describes COVID-19 vaccination coverage between rural and urban counties.
on (#5WQJB)
This report describes an analysis of HIV infection data collected during surveillance in Malawi.
on (#5WQJA)
This report describes use of type 2 oral poliovirus vaccine to treat a poliovirus outbreak in Tajikistan.
on (#5WMZZ)
This report describes mRNA COVID-19 vaccine effectiveness in preventing emergency department and urgent care encounters as well as hospitalizations among children and adolescents.
on (#5WMZY)
This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years.
on (#5WGXK)
This report describes how Omicron infection resulted in high transmission among household contacts. Prevention strategies are important to reduce transmission in households.
on (#5WFPD)
This report describes a recommendation for using a 4-month regimen for the treatment of drug-susceptible pulmonary tuberculosis.
on (#5WFPC)
This report describes updated guidance on use of the Ebola vaccine.
on (#5WFPB)
This report describes age-adjusted suicide rates for males and females in the U.S.
on (#5WFP9)
This report describes the NFL’s test-to-release COVID-19 mitigation strategy.
on (#5WFP8)
This report describes changes in U.S. suicide rates from 2019 to 2020.
on (#5WFP7)
This report describes the percentage of positive antigen test results following COVID-19 isolation.
on (#5W9ND)
This report describes increases in emergency department visits for mental health conditions among adolescent females in 2020, 2021, and 2022.